Vural Kesik

673 total citations
43 papers, 487 citations indexed

About

Vural Kesik is a scholar working on Epidemiology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Vural Kesik has authored 43 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Vural Kesik's work include Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Vural Kesik is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Vural Kesik collaborates with scholars based in Türkiye, Serbia and United Kingdom. Vural Kesik's co-authors include Vedat Köseoğlu, Erol Kısmet, Bülent Uysal, Emin Öztaş, Turan Tunç, Bülent Kurt, Ahmet Güven, Mustafa Kul, Erkan Demirkaya and Yıldırım Karslıoğlu and has published in prestigious journals such as Toxicology Letters, Acta Paediatrica and Journal of Pediatric Gastroenterology and Nutrition.

In The Last Decade

Vural Kesik

41 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vural Kesik Türkiye 12 93 81 74 71 66 43 487
Ítalo Medeiros Azevedo Brazil 12 120 1.3× 41 0.5× 51 0.7× 53 0.7× 56 0.8× 62 427
Mustafa Saçar Türkiye 15 191 2.1× 86 1.1× 109 1.5× 66 0.9× 51 0.8× 53 559
Fatih Oğuz Türkiye 14 117 1.3× 99 1.2× 148 2.0× 47 0.7× 47 0.7× 42 638
Jason Chou Taiwan 12 75 0.8× 78 1.0× 72 1.0× 55 0.8× 63 1.0× 24 441
Massood Hosseinzadeh Iran 14 85 0.9× 28 0.3× 63 0.9× 70 1.0× 45 0.7× 66 607
Hirokazu Oyamada Japan 10 163 1.8× 39 0.5× 35 0.5× 55 0.8× 61 0.9× 39 423
Roberto Cotellese Italy 12 139 1.5× 29 0.4× 53 0.7× 52 0.7× 58 0.9× 95 547
Konstantinos Ioannidis Greece 11 96 1.0× 65 0.8× 26 0.4× 117 1.6× 47 0.7× 26 500
Cabir Alan Türkiye 13 136 1.5× 68 0.8× 104 1.4× 32 0.5× 33 0.5× 50 565
Annelies Draisma Netherlands 11 67 0.7× 29 0.4× 49 0.7× 157 2.2× 66 1.0× 16 536

Countries citing papers authored by Vural Kesik

Since Specialization
Citations

This map shows the geographic impact of Vural Kesik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vural Kesik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vural Kesik more than expected).

Fields of papers citing papers by Vural Kesik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vural Kesik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vural Kesik. The network helps show where Vural Kesik may publish in the future.

Co-authorship network of co-authors of Vural Kesik

This figure shows the co-authorship network connecting the top 25 collaborators of Vural Kesik. A scholar is included among the top collaborators of Vural Kesik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vural Kesik. Vural Kesik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kesik, Vural, et al.. (2017). Evaluation of children with lympadenopathy. Türk Pediatri Arşivi. 49(1). 30–35. 5 indexed citations
2.
Kesik, Vural, et al.. (2016). Myostatin as a Marker for Doxorubicin Induced Cardiac Damage.. PubMed. 46(1). 26–31. 4 indexed citations
3.
Kesik, Vural, et al.. (2015). Small intestinal lactoferrin and calprotectin levels in different stages of necrotizing enterocolitis in a rat model. Advances in Medical Sciences. 60(2). 199–203. 1 indexed citations
4.
Öztürk, Metin İshak, Elgin Özkan, Vural Kesik, et al.. (2015). Serum chitotriosidase levels in cancer patients undergoing high dose chemotherapy and stem cell transplantation.. PubMed. 19(18). 3433–7. 1 indexed citations
5.
Kesik, Vural, et al.. (2015). Ozone Ameliorates Doxorubicine-Induced Skin Necrosis - results from an animal model. The International Journal of Lower Extremity Wounds. 15(3). 248–254. 7 indexed citations
6.
Balcı, Elçin, Oğuzhan Babacan, Abdülbaki Karaoğlu, et al.. (2014). Prevalence and risk factors of tinea capitis and tinea pedis in school children in Turkey.. PubMed. 64(5). 514–8. 18 indexed citations
7.
Karaoğlu, Abdülbaki, et al.. (2014). Bir askeri hastanenin çocuk polikliniğine başvurançocukların 0-24 ay arasındaki aşılama durumlarınındeğerlendirilmesi. 56(1). 13–16. 1 indexed citations
8.
Balcı, Elçin, Abdülbaki Karaoğlu, Vural Kesik, et al.. (2013). Prevalence and risk factors of onychomycosis in primary school children living in rural and urban areas in Central Anatolia of Turkey. Indian Journal of Dermatology Venereology and Leprology. 79(6). 777–777. 18 indexed citations
9.
Kesik, Vural, Bülent Kurt, Turan Tunç, et al.. (2010). Melatonin Ameliorates Doxorubicin-induced Skin Necrosis in Rats. Annals of Plastic Surgery. 65(2). 250–253. 14 indexed citations
10.
Kesik, Vural, Mükerrem Safalı, Elvan Çağlar Çıtak, Erol Kısmet, & Vedat Köseoğlu. (2010). Primary gastric burkitt lymphoma: a rare cause of intraabdominal mass in childhood. Pediatric Surgery International. 26(9). 927–929. 7 indexed citations
11.
Kesik, Vural, et al.. (2010). Effect of proanthocyanidin, arginine and glutamine supplementationon methotrexate-induced gastrointestinal toxicity in rats. Methods and Findings in Experimental and Clinical Pharmacology. 32(9). 657–657. 8 indexed citations
12.
Küpeli, Serhan, et al.. (2010). PRIMARY CUTANEOUS ANAPLASTIC LARGE CELL LYMPHOMA. Pediatric Hematology and Oncology. 27(7). 558–563. 3 indexed citations
13.
Kesik, Vural, Bilgehan Yalçın, Zühal Akçören, et al.. (2010). A RARE TYPE OF RENAL CELL CARCINOMA IN A GIRL: Hybrid Renal Cell Carcinoma. Pediatric Hematology and Oncology. 27(3). 228–232. 2 indexed citations
14.
Tunç, Turan, Vural Kesik, Hilmi Demirin, et al.. (2009). Effects of aminoguanidine and melatonin on intestinal ischemia/reperfusion injury in rats: An assessor-blinded, controlled experimental study. Current Therapeutic Research. 70(6). 449–459. 4 indexed citations
15.
Erdem, Onur, Emin Öztaş, Vural Kesik, et al.. (2009). Proanthocyanidin prevents methotrexate-induced intestinal damage and oxidative stress. Experimental and Toxicologic Pathology. 62(2). 109–115. 44 indexed citations
16.
Kesik, Vural, Ahmet Güven, Turan Tunç, et al.. (2009). Melatonin and 1400 W Ameliorate both Intestinal and Remote Organ Injury Following Mesenteric Ischemia/Reperfusion. Journal of Surgical Research. 157(1). e97–e105. 37 indexed citations
17.
Kesik, Vural, Yılmaz Yozgat, Erkan Sarı, et al.. (2009). HEPATOBLASTOMA METASTATIC TO THE RIGHT ATRIUM RESPONDING TO CHEMOTHERAPY ALONE. Pediatric Hematology and Oncology. 26(8). 583–588. 5 indexed citations
18.
Kesik, Vural, et al.. (2008). Hematopoietic stem cell transplantation in Langerhans cell histiocytosis: Case report and review of the literature. Pediatric Transplantation. 13(3). 371–374. 9 indexed citations
19.
Kesik, Vural, Mustafa Koray Lenk, Cengiz Açıkel, et al.. (2008). Do Zinc and Selenium Prevent the Antioxidant, Hepatic and Renal System Impairment Caused by Aspirin in Rats?. Biological Trace Element Research. 123(1-3). 168–178. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026